Trials (Helsinki University Hospital Comprehensive Cancer Center): Revision history

14 December 2025

• curprev 14:1414:14, 14 December 2025‎ Francine talk contribs‎ 28,375 bytes +227‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 28,148 bytes +1,701‎ Update categories. undo

2 December 2025

• curprev 20:2620:26, 2 December 2025‎ Francine talk contribs‎ 26,447 bytes +7‎ No edit summary undo
• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 26,440 bytes +3,136‎ Update categories. undo

5 November 2024

• curprev 23:4523:45, 5 November 2024‎ Victor talk contribs‎ 23,304 bytes +12‎ No edit summary undo

4 January 2024

• curprev 15:1715:17, 4 January 2024‎ Francine talk contribs‎ 23,292 bytes +361‎ No edit summary undo

1 December 2023

• curprev 20:0720:07, 1 December 2023‎ Francine talk contribs‎ 22,931 bytes +130‎ No edit summary undo
• curprev 20:0520:05, 1 December 2023‎ Francine talk contribs‎ 22,801 bytes +22,801‎ Created page with "'''NCTID''': NCT04657991 '''Title''': A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma '''Study Summary''': The purpose of this study is to learn about the effects of three study medicines (encorafenib, binimetinib, and pembrolizumab) given together for the treatment of melanoma that: * is advanced or metastatic (spread to other parts of the body); * has a certain type of abnormal..."